Search by Medical Condition

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Clinical Trials for Neuromyelitis Optica

• Long-term, Open-label, Safety Study of Inebilizumab in Neuromyelitis Optica Spectrum Disorder (NMOSD)
• A Phase IIb Study of Nabiximols for Spasticity Due to Neuromyelitis Optica Spectrum Disorders
• Efficacy and Safety of Ruxolitinib in Neuromyelitis Optica Spectrum Disorders
• Monitoring of Azathioprine Metabolite Concentrations and Cytokine Levels in Neuromyelitis Optica Spectrum Disorder
• Evaluate the Safety and Efficacy of CAR-T Cells in the Treatment of R/R Neuromyelitis Optica
• Efficacy and Safety of Baricitinib in Neuromyelitis Optica Spectrum Disorders
• Efficacy and Safety of Divozilimab in Patients With Neuromyelitis Optica Spectrum Disorders (AQUARELLE)
• Efficacy and Safety of Mitoxantrone Hydrochloride Liposome Injection in the Treatment of Neuromyelitis Optica Spectrum Disorder (NMOSD)
• Study of Inebilizumab in Pediatric Subjects With Neuromyelitis Optica Spectrum Disorder
• Ofatumumab in AQP4-IgG Seropositive NMOSD
• A Phase I Study of LP-168 in Healthy Volunteers
• Safety and Efficacy of Daratumumab in Patients With Anti-Aquaporin 4 Antibody Positive Neuromyelitis Optica Spectrum Disorders
• An Open Label Study of the Effects and Safety of Zanubrutinib in NMOSDs Adult Patients
• Phase 2/3 Efficacy and Safety Study of Ravulizumab IV in Pediatric Participants With NMOSD
• A Study of MIL62 in Patients With Neuromyelitis Optica Spectrum Disorder (NMOSD)
• A Study of Orelabrutinib in Patients With AQP4-IgG Positive Neuromyelitis Optica Spectrum Disorder
• A Study In Neuromyelitis Optica Spectrum Disorder (NMOSD) With Satralizumab As An Intervention
• A Study To Evaluate Pharmacokinetics, Efficacy, Safety, Tolerability, And Pharmacodynamics Of Satralizumab In Pediatric Patients With Aquaporin-4 Antibody Positive Neuromyelitis Optica Spectrum Disorder (NMOSD)
• Efficacy and Safety of Belimumab in Neuromyelitis Optica Spectrum Disorders
• Clinical Study of B001 Injection in Subjects With Neuromyelitis Optic Spectrum Disorder (NMOSD)
• An Open Label Study of the Effects of SHR1459 in NMOSDs Patients
• A Study to Evaluate the Safety and Efficacy of Satralizumab in Participants With Neuromyelitis Optica Spectrum Disorder (NMOSD)
• Safety and Efficacy of CT103A Cells for Relapsed/Refractory Antibody-associated Idiopathic Inflammatory Diseases of the Nervous System
• Rituximab at Low dosE for neuromyelitiS optiCa spectrUm disordEr (RESCUE)
• A Study of HBM9161 in NMOSD Patients
• A Study of the Safety and Activity of Eculizumab in Pediatric Participants With Relapsing Neuromyelitis Optica Spectrum Disorder
• A Phase I Clinical Trial of BAT4406F Injection in Patients With Neuromyelitis Optica Spectrum Disorders
• Autologous Transplant To End NMO Spectrum Disorder
• Tocilizumab vs Azathioprine in Neuromyelitis Optica Spectrum Disorders
• Central Pain Study for ABX-1431
• A Longitudinal Study of ACTEMRA® (Tocilizumab) as Monotherapy in Highly Active NMOSD
• Comparison of Clinical Effects of Azathioprine and Rituximab NMO-SD Patients
• Efficacy and Safety of Bortezomib as add-on Treatment in Relapsing Neuromyelitis Optica Spectrum Disorder
• Neuromyelitis Optica (NMO) & Cetirizine
• Mycophenolate Mofetil Treatment With Neuromyelitis Optica Spectrum Disorders in Chinese Patients
• A Multicentre randomiSed Controlled TRial of IntraVEnous Immunoglobulin Versus Standard Therapy for Transverse Myelitis
• Ublituximab for Acute Neuromyelitis Optica (NMO) Relapses
• N-MOmentum: A Clinical Research Study of Inebilizumab in Neuromyelitis Optica Spectrum Disorders
• Safety and Efficacy of Sustained Release Dalfampridine in Transverse Myelitis (Re-Launch)
• Pilot Study of alpha1-antitrypsin to Treat Neuromyelitis Optica Relapses
• Efficacy and Safety Study of Satralizumab (SA237) as Monotherapy to Treat Participants With Neuromyelitis Optica (NMO) and Neuromyelitis Optica Spectrum Disorder (NMOSD)
• Efficacy and Safety Study of Satralizumab (SA237) as Add-on Therapy to Treat Participants With Neuromyelitis Optica (NMO) and NMO Spectrum Disorder (NMOSD)
• Efficacy and Safety of Mitoxantrone in Patients With Refractory Neuromyelitis Optica and Spectrum Disorders
• A Randomized Controlled Trial of Eculizumab in AQP4 Antibody-positive Participants With NMO (PREVENT Study)
• Phase II Clinical Trial of NPB-01 in Patients With Anti-aquaporin 4 Antibody Positive Neuromyelitis Optica Spectrum Disorder Not Provided Adequate Effect of Therapy to Steroids Plus Therapy.
• Efficacy of Bevacizumab (Avastin) in Treatment of Acute NMO Exacerbations
• C1-esterase Inhibitor (Cinryze) for Acute Treatment of Neuromyelitis Optica Exacerbation
• Safety and Efficacy of Sustained Release Dalfampridine in Transverse Myelitis (Re-Launch)
• An Open Label Study of the Effects of Eculizumab in Neuromyelitis Optica
• Hematopoietic Stem Cell Transplant in Devic's Disease
• Autologous Peripheral Blood Stem Cell Transplant for Neurologic Autoimmune Diseases
• Safety and Tolerability of Rituximab in Neuromyelitis Optica
• A Pilot Study of Mitoxantrone for the Treatment of Recurrent Neuromyelitis Optica (Devic's Disease)